Attenuated Mannheimia haemolytica Vaccines and Methods of Making and Use
    22.
    发明申请
    Attenuated Mannheimia haemolytica Vaccines and Methods of Making and Use 有权
    减毒的Mannheimia haemolytica疫苗和制造和使用方法

    公开(公告)号:US20160199477A1

    公开(公告)日:2016-07-14

    申请号:US14991003

    申请日:2016-01-08

    Applicant: Merial Inc.

    Abstract: The present invention provides attenuated M. haemolitica strains that elicit an immune response in animal against M. haemolitica, compositions comprising said strains, methods of vaccination against M. haemolitica, and kits for use with such methods and compositions. The invention further provides multi-valent vaccines, which provide protective immunity when administered in an effective amount to animals susceptible to “shipping fever” or bovine respiratory disease.

    Abstract translation: 本发明提供减毒的血液流行性感冒菌株,其在动物中引起血红蛋白溶血性免疫应答,包含所述菌株的组合物,针对血蓝单胞菌疫苗接种的方法,以及用于此类方法和组合物的试剂盒。 本发明还提供了多价疫苗,当以有效量向易感“运送发热”或牛呼吸道疾病的动物施用时提供保护性免疫。

    Hyperbaric Device and Methods for Producing Inactivated Vaccines and for Refolding/Solubilizing Recombinant Proteins
    28.
    发明申请
    Hyperbaric Device and Methods for Producing Inactivated Vaccines and for Refolding/Solubilizing Recombinant Proteins 审中-公开
    用于产生灭活疫苗和重折叠/重组蛋白质的高压装置和方法

    公开(公告)号:US20160000896A1

    公开(公告)日:2016-01-07

    申请号:US14851457

    申请日:2015-09-11

    Applicant: Merial Inc.

    Abstract: The invention relates to hyperbaric devices for inactivating microorganisms and viruses while retaining their immunogenicity and for making and producing the soluble, disaggregated, refolded or active immunogenic or therapeutic proteins from inclusion bodies produced from prokaryotes or eukaryotes. The invention encompasses hyperbaric methods for inactivating pathogenic organisms, and methods for producing vaccine compositions using the inactivated pathogens. The hyperbarically inactivated microorganisms are safer and more immunogenic than chemically inactivated microorganisms. Similarly, the solubilized proteins have superior properties compared to more heavily aggregated proteins, including reduced non-specific immune reactions.

    Abstract translation: 本发明涉及用于灭活微生物和病毒的高压装置,同时保留其免疫原性并用于制备和产生可从原核生物或真核生物产生的包涵体的可溶性,分解,重折叠或活性免疫原性或治疗性蛋白质。 本发明包括用于灭活致病生物体的高压方法,以及使用灭活病原体生产疫苗组合物的方法。 高温灭活的微生物比化学灭活的微生物更安全,更具免疫原性。 类似地,与更重聚集的蛋白质相比,溶解的蛋白质具有优异的性质,包括减少的非特异性免疫反应。

Patent Agency Ranking